The phrase on the box is 'inspired by popular needle-based procedures', which is a careful sentence, and the ingredient list rewards reading it carefully. Obagi's ELASTIderm Advanced Filler Concentrate, launched in 2024 as the line's first face-wide product, is a twenty-millilitre tube with a hard angled tip that lays a stroke of white cream directly into a wrinkle. Within a minute the line looks softer. That much is true, repeatable and, at least for fine expression lines and the little vertical lines above the lip, quite satisfying. What is doing it is eighth and ninth on the label: microcrystalline cellulose and a dimethicone/vinyl dimethicone crosspolymer, which is to say a light-scattering particle and a silicone elastomer, the two ingredients that have been the basis of every soft-focus primer for twenty years.
The rest of the formula supports that film well. Water, dimethicone and glycerin lead, with coco-caprylate for slip and pentylene glycol and diglycerin extending the humectant load; glyceryl stearate and cetearyl alcohol build the cream, shea butter and olive-derived esters give a small emollient phase so the film does not feel chalky on crepey skin, an acrylate copolymer and carbomer set the texture, chlorphenesin and caprylyl glycol preserve, beta-glucan sits in as a soothing gesture, and the peptide the product is named for, acetyl hexapeptide-1, is the twenty-third and last ingredient. No fragrance, no alcohol, no dyes, and a preservative choice mild enough for the lip and eye area. It is a clean, well-behaved formula for what it is.
The peptide deserves a careful paragraph because the name invites a misunderstanding. Acetyl hexapeptide-8, better known by its trade name and marketed for a decade as a topical alternative to muscle-relaxing injections, has a body of permeability and small efficacy studies behind it, and a 2025 review in the International Journal of Molecular Sciences went through that literature in detail, concluding that the evidence for wrinkle reduction is modest and constrained by how poorly the peptide crosses the stratum corneum. That is the peptide most buyers will think of when they see 'hexapeptide' on a wrinkle filler. This product does not contain it. Acetyl hexapeptide-1 is a different molecule, a mimic of the melanocortin hormone alpha-MSH, documented mainly for calming redness, supporting pigmentation and protecting against UV-related damage; Obagi calls it biomimetic and wrinkle-smoothing, and the supplier literature does not support the second half of that. At the tail of the list, in a product whose visible effect is fully explained by cellulose and silicone, it is a name on the box rather than a mechanism.
What the product actually delivers is worth describing plainly, because it is good at it. The tip is genuinely precise, better than a fingertip for tracing the elevens or the lines that fan from the outer eye, and the cream sets in about a minute to a velvety, matte, powdery film that takes foundation without changing its colour. Lines look blurred, skin over them feels smooth, and the brand's single-application tests reporting a large improvement in surface roughness are consistent with that. Over the following hours the glycerin and diglycerin draw water into the top layer, which is the plausible source of the 'maximum results at eight hours' claim, and by the evening cleanse everything is gone. Eight weeks in, most of Obagi's panel felt lines looked blurred and skin smoother, which is what happens when someone applies a well-made optical filler twice a day for eight weeks and looks in the mirror; it is not evidence that the wrinkle has changed. The hundred-odd reviews on Obagi's site, at 4.2 stars, say much the same in two voices: delighted at how lip lines and crow's feet soften under makeup, and disappointed that nothing lasts past washing and that deeper folds are untouched.
The practical limits are those of any elastomer film. Over-apply and it rolls into little balls under foundation or sunscreen, so the dose is a thin stroke, tapped in, with a full minute to set and a patting hand for whatever goes on top. It does nothing for etched, deep wrinkles or for volume loss, which is what people who actually want filler tend to have. The shea butter and silicone film make it a poor choice over active breakouts. And the tube is small: twenty millilitres, two to three months if four or five areas are treated twice daily.
Which brings the price. One hundred and twenty dollars for twenty millilitres is roughly six dollars a millilitre for a formula whose working parts are found in silicone primers at a fraction of that, and the physician-dispensed pedigree, real as Obagi's is in other lines, does not change what cellulose and elastomer do. The applicator is the one thing here that is hard to buy elsewhere at any price, and for someone who wants precise, fragrance-free line blurring around the mouth and eyes and does not want to fuss with a primer, that precision has value. For anyone hoping the word filler means what it means in a clinic, it does not.
This is a good product for fine expression lines, lip lines and crow's feet on someone who wants them softened under makeup for a day and appreciates exact placement and a gentle formula. It is not a treatment, not a substitute for a retinoid, and not a reason to skip the consultation for anyone whose lines are structural. Bought with clear eyes, it is a very well-made primer in a very small, very expensive tube.
